UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Antifibrotic Effects of Combined Treatment with Farnesoid X Receptor Agonist and Angiotensin-II Type1 Receptor Blocker on Hepatic Fibrogenesis in the Rat Model of Nonalcoholic Steatohepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S686-S686

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S582-S582

2016

Link zum Volltext

Verfügbarkeit prüfen

290 TAS-116, a Novel, Orally Bioavailable Highly Potent HSP90a/β Selective Inhibitor Demonstrates Favorable Tissue Distribution Properties Which Lead to Minimized Ocular Toxicity

European journal of cancer (1990), 2012-11, Vol.48, p.89-89

2012

Link zum Volltext

Verfügbarkeit prüfen

291 TAS-116, a Novel, Orally Bioavailable HSP90a/β Selective Inhibitor Demonstrates Highly Potent Antitumor Activity in Preclinical Models with a Favorable PK Profile

European journal of cancer (1990), 2012-11, Vol.48, p.89-89

2012

Link zum Volltext

Verfügbarkeit prüfen

FRI-086 - Possible liver regeneration and anti-fibrogenic effect of NOTCH1 selective inhibitor in the diseased liver model

Journal of hepatology, 2018-04, Vol.68, p.S399-S399

2018

Link zum Volltext

Verfügbarkeit prüfen

Possible liver regeneration and anti-fibrogenic effect of NOTCH1 selective inhibitor in the diseased liver model

Journal of hepatology, 2018-04, Vol.68, p.S399

2018

Link zum Volltext

Verfügbarkeit prüfen

292 Evolution of Highly Selective HSP90a/β Inhibitors with Unique Binding Mode

European journal of cancer (1990), 2012-11, Vol.48, p.89-89

2012

Link zum Volltext

Verfügbarkeit prüfen

Moderate alcohol consumption protects against fatty liver in males

Journal of hepatology, 2018-04, Vol.68, p.S841

2018

Link zum Volltext

Verfügbarkeit prüfen

SAT-526 - Moderate alcohol consumption protects against fatty liver in males

Journal of hepatology, 2018-04, Vol.68, p.S841-S841

2018

Link zum Volltext

Verfügbarkeit prüfen

SAT-320 - Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Journal of hepatology, 2018-04, Vol.68, p.S752-S752

2018

Link zum Volltext

Verfügbarkeit prüfen

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Journal of hepatology, 2018-04, Vol.68, p.S752

2018

Link zum Volltext

Verfügbarkeit prüfen

Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression

Journal of hepatology, 2018-04, Vol.68, p.S224

2018

Link zum Volltext

Verfügbarkeit prüfen

THU-215 - Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression

Journal of hepatology, 2018-04, Vol.68, p.S224-S224

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of combined farnesoid X receptor agonist (INT747) and dipeptidyl peptidase-4 inhibitor (sitagliptin) on liver fibrosis

Journal of hepatology, 2018-04, Vol.68, p.S335-S336

2018

Link zum Volltext

Verfügbarkeit prüfen

THU-454 - Effect of combined farnesoid X receptor agonist (INT747) and dipeptidyl peptidase-4 inhibitor (sitagliptin) on liver fibrosis

Journal of hepatology, 2018-04, Vol.68, p.S335-S336

2018

Link zum Volltext

Verfügbarkeit prüfen

SAT-336 - Antifibrotic Effects of Combined Treatment with Farnesoid X Receptor Agonist and Angiotensin-II Type1 Receptor Blocker on Hepatic Fibrogenesis in the Rat Model of Nonalcoholic Steatohepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S686-S686

2016

Link zum Volltext

Verfügbarkeit prüfen

FRI-097 - Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S582-S582

2016

Link zum Volltext

Verfügbarkeit prüfen

Combination of vitamin K 2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression

Journal of hepatology, 2005-05, Vol.42 (5), p.687-693

2005

Link zum Volltext

Verfügbarkeit prüfen

Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats

Journal of hepatology, 2006-03, Vol.44 (3), p.568-575

2006

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development

Journal of hepatology, 2004-07, Vol.41 (1), p.97-103

2004

Link zum Volltext

Verfügbarkeit prüfen

Effective irreversible alkylating reagents based on the structure of clavulones

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.837-840

2004

Link zum Volltext

Verfügbarkeit prüfen

Second-look laparoscopy after laparoscopic myomectomy

The Journal of the American Association of Gynecologic Laparoscopists, 2004-08, Vol.11 (3), p.S76-S77

2004

Link zum Volltext

Verfügbarkeit prüfen

Development of a novel, safe method for laparoscopic entry

The Journal of the American Association of Gynecologic Laparoscopists, 2004-08, Vol.11 (3), p.S34-S34

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of pneumoperitoneum and postural change of hemodynamics during laparoscopic operation

The Journal of the American Association of Gynecologic Laparoscopists, 2004-08, Vol.11 (3), p.S20-S20

2004

Link zum Volltext

Verfügbarkeit prüfen

Methods of laparoscopic surgery and anesthesia for ovarian cysts in pregnancy

The Journal of the American Association of Gynecologic Laparoscopists, 2004-08, Vol.11 (3), p.S57-S57

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(25)
Physical Sciences
(15)
Animals
(13)
Biological And Medical Sciences
(12)
Humans
(10)
Medical Sciences
(10)
Chemistry
(9)
Biochemistry & Molecular Biology
(8)
Chemistry, Organic
(7)
Pharmacology & Pharmacy
(7)
Chemistry, Medicinal
(6)
Gastroenterology & Hepatology
(6)
Male
(6)
Exact Sciences And Technology
(5)
Pharmacology. Drug Treatments
(5)
Rats
(5)
Enzyme Inhibitors - Pharmacology
(4)
Gastroenterology. Liver. Pancreas. Abdomen
(4)
Mice
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier ScienceDirect Journals Complete
(56)
Ingenta
(55)
MEDLINE
(23)
Journals@Ovid Complete
(23)
IngentaConnect Journals
(12)
EZB Free E-Journals
(5)
Springer Book Series
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antifibrotic Effects of Combined Treatment with Farnesoid X Receptor Agonist and Angiotensin-II Type1 Receptor Blocker on Hepatic Fibrogenesis in the Rat Model of Nonalcoholic Steatohepatitis

Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis

290 TAS-116, a Novel, Orally Bioavailable Highly Potent HSP90a/β Selective Inhibitor Demonstrates Favorable Tissue Distribution Properties Which Lead to Minimized Ocular Toxicity

291 TAS-116, a Novel, Orally Bioavailable HSP90a/β Selective Inhibitor Demonstrates Highly Potent Antitumor Activity in Preclinical Models with a Favorable PK Profile

FRI-086 - Possible liver regeneration and anti-fibrogenic effect of NOTCH1 selective inhibitor in the diseased liver model

Possible liver regeneration and anti-fibrogenic effect of NOTCH1 selective inhibitor in the diseased liver model

292 Evolution of Highly Selective HSP90a/β Inhibitors with Unique Binding Mode

Moderate alcohol consumption protects against fatty liver in males

SAT-526 - Moderate alcohol consumption protects against fatty liver in males

SAT-320 - Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression

THU-215 - Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression

Effect of combined farnesoid X receptor agonist (INT747) and dipeptidyl peptidase-4 inhibitor (sitagliptin) on liver fibrosis

THU-454 - Effect of combined farnesoid X receptor agonist (INT747) and dipeptidyl peptidase-4 inhibitor (sitagliptin) on liver fibrosis

SAT-336 - Antifibrotic Effects of Combined Treatment with Farnesoid X Receptor Agonist and Angiotensin-II Type1 Receptor Blocker on Hepatic Fibrogenesis in the Rat Model of Nonalcoholic Steatohepatitis

FRI-097 - Impact of the Combination of Dipeptidyl Peptidase IV Inhibitor and Angiotensin-II Type 1 Receptor Blocker on Hepatocarcinogenesis in a Rat Model of Nonalcoholic Steatohepatitis

Combination of vitamin K 2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression

Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats

Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development

Effective irreversible alkylating reagents based on the structure of clavulones

Second-look laparoscopy after laparoscopic myomectomy

Development of a novel, safe method for laparoscopic entry

Effects of pneumoperitoneum and postural change of hemodynamics during laparoscopic operation

Methods of laparoscopic surgery and anesthesia for ovarian cysts in pregnancy

Aktive Filter

Suchergebnisse filtern